NEW YORK (GenomeWeb News) – Prodesse’s molecular diagnostic test for H1N1 swine flu infections has been cleared by EU regulators for commercialization in Europe.

The firm, which recently became a subsidiary of Gen-Probe, received the CE Mark clearance for its ProFlu-ST assay as a diagnostic to differentiate among influenza strains.

The RT-PCR-based test detects and identifies the 2009 H1N1 virus, the seasonal influenza A/H1 virus, and the seasonal A/H3 virus.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: the Human Silencing Hub protein complex, and more.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.